R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
Digital Sponsored Scaling AI in life sciences: From automation to strategic tr... When talking about AI in pharma and life sciences marketing, we often focus on the automation of content creation, management, and delivery.
R&D Driving data & analytics transformation in life sciences The field of life sciences is witnessing a remarkable era of innovation, characterised by breakthroughs across scientific domains that are revolutionising drug discovery and development.
Partner Content Partner Content Wilmington Healthcare wins first client for new NHS transfor... Product helps pharma identify opportunities and tailor
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.